1. Home
  2. CADL vs NATH Comparison

CADL vs NATH Comparison

Compare CADL & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$4.91

Market Cap

357.4M

Sector

Health Care

ML Signal

HOLD

Logo Nathan's Famous Inc.

NATH

Nathan's Famous Inc.

HOLD

Current Price

$100.72

Market Cap

411.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
NATH
Founded
1999
1916
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
357.4M
411.7M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
CADL
NATH
Price
$4.91
$100.72
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$19.71
N/A
AVG Volume (30 Days)
1.2M
20.4K
Earning Date
03-12-2026
02-05-2026
Dividend Yield
N/A
1.98%
EPS Growth
58.62
22.29
EPS
N/A
4.17
Revenue
$125,000.00
$104,201,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$24.18
Revenue Growth
N/A
7.81
52 Week Low
$4.25
$88.00
52 Week High
$7.24
$118.32

Technical Indicators

Market Signals
Indicator
CADL
NATH
Relative Strength Index (RSI) 47.72 54.64
Support Level $4.58 $100.25
Resistance Level $5.42 $102.05
Average True Range (ATR) 0.26 0.36
MACD 0.00 -0.03
Stochastic Oscillator 61.42 62.67

Price Performance

Historical Comparison
CADL
NATH

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About NATH Nathan's Famous Inc.

Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: